Page last updated: 2024-09-05

phosphatidylcholines and 10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid

phosphatidylcholines has been researched along with 10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid in 1 studies

Compound Research Comparison

Studies
(phosphatidylcholines)
Trials
(phosphatidylcholines)
Recent Studies (post-2010)
(phosphatidylcholines)
Studies
(10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid)
Trials
(10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid)
Recent Studies (post-2010) (10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid)
32,2044435,5933103

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antón, R; Camacho, M; Puig, L; Vila, L1

Other Studies

1 other study(ies) available for phosphatidylcholines and 10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid

ArticleYear
Hepoxilin B3 and its enzymatically formed derivative trioxilin B3 are incorporated into phospholipids in psoriatic lesions.
    The Journal of investigative dermatology, 2002, Volume: 118, Issue:1

    Topics: 8,11,14-Eicosatrienoic Acid; Cytosol; Epidermal Cells; Epidermis; Epoxide Hydrolases; Esterification; Humans; Hydroxyeicosatetraenoic Acids; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Psoriasis; Reference Values; Skin

2002